IL17A and metabolic dysfunction-associated steatohepatitis: Nevertheless, some studies still demonstrated a protective role for endogenous IL-22 against liver inflammation and fibrosis, particularly in MCD-induced MASH, but such effect was contingent on the absence of the IL-17 cytokine (Il17a-/-) (147).